YONGHE MED.GR.DL-0000025 (L97) — Capital Reinvestment Ratio
YONGHE MED.GR.DL-0000025 (L97) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (€495.53 Million) in capital expenditures (€18.90 Million). See debt-free asset ratio of YONGHE MED.GR.DL-0000025 to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
YONGHE MED.GR.DL-0000025 Capital Reinvestment Ratio (2021–2025)
This chart tracks YONGHE MED.GR.DL-0000025's Capital Reinvestment Ratio across 3 annual periods. Check L97 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for YONGHE MED.GR.DL-0000025 (2021–2025)
Year-by-year Capital Reinvestment Ratio for YONGHE MED.GR.DL-0000025 from 2021 to 2025. For live market cap and broader valuation context, see L97 company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | €495.53 Million | €18.90 Million | ▼ -83.8% |
| 2024 | 0.24x | €228.62 Million | €53.76 Million | ▼ -46.1% |
| 2021 | 0.44x | €437.28 Million | €190.64 Million | — |